N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

Compounds of formula (I)processes for their production and their use as pharmaceuticals.

Saved in:
Bibliographic Details
Main Authors SÜLZLE, Detlev, SIEGEL, Stephan, KLAR, Ulrich, SCHRÖDER, Jens, BÖMER, Ulf, KAPLAN, Bethany, GRAHAM, Keith, SIEGEL, Franziska, SCHULZE, Volker, KORR, Daniel, MORTIER, Jeremie Xavier G, GREULICH, Heidi, BERGER, Markus, MEYERSON, Matthew
Format Patent
LanguageEnglish
Published 28.12.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PHYSICS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I)processes for their production and their use as pharmaceuticals.
Bibliography:Application Number: US202318315472